May 18, 2017 13:06 pm UTC| Business
Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia Data to be presented at ASCO and...
May 18, 2017 13:06 pm UTC| Business
Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia Data to be presented at ASCO and...
May 18, 2017 13:06 pm UTC| Business
Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia Data to be presented at ASCO and...
May 18, 2017 13:06 pm UTC| Business
Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia Data to be presented at ASCO and...
May 18, 2017 13:06 pm UTC| Business
Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia Data to be presented at ASCO and...
B. Riley Financial to Acquire Wunderlich Securities
May 18, 2017 13:06 pm UTC| Business
LOS ANGELES, May 18, 2017 -- B. Riley Financial, Inc. (NASDAQ:RILY), a diversified financial services company, has signed a definitive agreement to acquire Memphis-based Wunderlich Securities ("Wunderlich"), a leading...
B. Riley Financial to Acquire Wunderlich Securities
May 18, 2017 13:06 pm UTC| Business
LOS ANGELES, May 18, 2017 -- B. Riley Financial, Inc. (NASDAQ:RILY), a diversified financial services company, has signed a definitive agreement to acquire Memphis-based Wunderlich Securities ("Wunderlich"), a leading...
India's 2025 Trade Push: Major FTAs & Global Partnerships Secured